Antibacterial Drugs Market 2015 World Analysis and Forecast to 2023 Antibacterial Drugs Market - Global Industry Analy | Page 2

The report also profiles major players in the antibacterial drugs market based on various attributes
such as company overview, financial overview, business strategies, product portfolio and recent
developments. Some of the major players profiled in this report include Allergan plc, AstraZeneca plc,
Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline
plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi.
Get accurate market forecast and analysis on the Antibacterial Drugs market. Request a sample to stay
abreast on the key trends impacting this market.
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1567
The global antibacterial drugs market is segmented as follows:
Global Antibacterial Drugs Market, by Drug Class, 2013 – 2023 (USD Million)
 Aminoglycosides
 B-Lactams
 Tetracyclines
 Sulfonamides
 Quinolones/Fluoroquinolones
 Macrolides
 Phenicols
 Miscellaneous Antibacterials
Pipeline Analysis of Antibacterial Drugs Market
 Actoxumab/Aezlotoxumab, (MK-3415A)
 Surotomycin (MK-4261)
 Arikace
 Cadazolid
 Ciprofloxacin/Fluocinolone Acetonide
 Zempia (E-101)
 Carbavance (meropenem/RPX7009)
 Ozenoxacin
 RHB-105
 SPL7013
 Delafloxacin
 Solithromycin (CEM-101)
 Eravacycline
 Delamanid
 SYM-1219
 Omadacycline (PTK-0796)
 Plazomycin
Global Antibacterial Drugs Market, by Geography, 2013 – 2023 (USD Million)
 North America
o U.S.
o Canada